|
|
Volumn 366, Issue 9500, 2005, Pages 1845-1847
|
|
Roflumilast for chronic obstructive pulmonary disease [1] (multiple letter)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
PHOSPHODIESTERASE IV INHIBITOR;
PLACEBO;
ROFLUMILAST;
XANTHINE;
AMINOPYRIDINE DERIVATIVE;
BENZAMIDE DERIVATIVE;
BRONCHODILATING AGENT;
CYCLOPROPANE DERIVATIVE;
PHOSPHODIESTERASE INHIBITOR;
AIRWAY OBSTRUCTION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CIGARETTE SMOKING;
CLINICAL TRIAL;
DIARRHEA;
DISEASE EXACERBATION;
DRUG MEGADOSE;
FORCED EXPIRATORY VOLUME;
HEALTH CARE;
HUMAN;
LETTER;
LUNG FUNCTION;
MORBIDITY;
MORTALITY;
NAUSEA;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RISK REDUCTION;
STATISTICAL SIGNIFICANCE;
DRUG EFFECT;
FORCED EXPIRATORY FLOW;
INFLAMMATION;
NOTE;
SMOKING;
HEALTH PERSONNEL ATTITUDE;
LUNG FUNCTION TEST;
TREATMENT FAILURE;
AMINOPYRIDINES;
BENZAMIDES;
BRONCHODILATOR AGENTS;
CYCLOPROPANES;
FORCED EXPIRATORY FLOW RATES;
HUMANS;
INFLAMMATION;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
SMOKING;
PHOSPHODIESTERASE INHIBITORS;
ATTITUDE OF HEALTH PERSONNEL;
RESPIRATORY FUNCTION TESTS;
TREATMENT FAILURE;
|
|
EID: 28044468204
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)67746-X Document Type: Letter |
|
Times cited : (2)
|
|
References (3)
|
